Dr Bhawna Sirohi said high costs, limited access to genomic testing and expensive targeted drugs remain barriers to precision oncology, ... This GujjuTicks brief summarizes the headline for local readers; read the full story on the publisher site.
This is a short GujjuTicks summary for discovery. Full reporting and quotes belong to the original publisher.